Clinical trial · Observational
The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
NCT01310062CI-TRIAL-00004525unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma,Hepatocellular | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Hepatitis B,Chronic | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Patients of at least 21 years old on day of giving consent for study * Patients must be able and wiling to give an informed consent * Patient with chronic HBV infection * Patient with active hepatocellular carcinoma and chronic hepatitis B * Healthy subjects Exclusion Criteria: * Patients who have co-infection with HIV or chronic hepatitis C * Subjects with other types of cancer
References
Publications (0)
Data not yet available
No reference posted for this study.